These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37937195)

  • 1. Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation.
    Kakodkar P; Zhao Y; Pan H; Wu F; Pearce T; Webster D; Elemary M; Sabry W; Kwan L; Pelzer L; Bosch M; Sherwood KR; Lan J; Tran J; Liwski R; Keown P; Mostafa A
    Front Genet; 2023; 14():1282947. PubMed ID: 37937195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.
    Liacini A; Tripathi G; McCollick A; Gravante C; Abdelmessieh P; Shestovska Y; Mathew L; Geier S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation.
    Lee H; Chae SW; Cho SI; Lee JS; Kim MJ; Seong MW
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods.
    Brow D; Shike H; Kendrick J; Pettersson L; Mineishi S; Claxton DF; Wirk B; Cioccio J; Greiner RJ; Viswanatha D; Kharfan-Dabaja MA; Li Z; Tyler J; Elrefaei M
    Hum Immunol; 2024 May; 85(3):110794. PubMed ID: 38553384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome.
    Lee JM; Kim YJ; Park SS; Han E; Kim M; Kim Y
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31795155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCR.
    Zhang A; Macecevic S; Thomas D; Allen J; Mandley S; Kawczak P; Jurcago R; Tyler J; Casey H; Bosler D; Sobecks R; Hamilton B; Sauter C; Mineishi S; Claxton D; Shike H
    J Mol Diagn; 2024 Apr; 26(4):233-244. PubMed ID: 38307253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism Assay Using Single Nucleotide Polymorphisms Adjacent and in Linkage-Disequilibrium Enables Sensitive Disease Relapse Monitoring after Hematopoietic Stem-Cell Transplantation.
    Kim J; Yun W; Park YJ; Seo J; Lee RDW; Shin S; Lee HJ; Kim IS; Choi JR; Lee ST
    Clin Chem; 2021 Apr; 67(5):781-787. PubMed ID: 33582770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Next-Generation Sequencing and Crystal Digital PCR for Chimerism Monitoring of Post-Allogeneic Hematopoietic Stem Cell Transplantation.
    Pedini P; Cherouat N; Basire A; Simon S; Budon L; Pourtein M; Grondin S; Moskovtchenko P; Chiaroni J; Michel G; Frassati C; Picard C
    Transplant Cell Ther; 2021 Jan; 27(1):89.e1-89.e10. PubMed ID: 32980546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of chimerism analysis to allogeneic hematopoietic stem cell transplantation by STR-PCR].
    Sun JF; Han XP; Zhao DD; Wang FF; Jin HJ; Gao CJ; DA WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):337-41. PubMed ID: 17493343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of chimerism testing by next generation sequencing.
    Cusick MF; Clark L; Tu T; Goforth J; Zhang X; LaRue B; Gutierrez R; Jindra PT
    Hum Immunol; 2022 Jan; 83(1):61-69. PubMed ID: 34728094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and performance of a next generation sequencing (NGS) assay for monitoring of mixed chimerism.
    Pettersson L; Vezzi F; Vonlanthen S; Alwegren K; Hedrum A; Hauzenberger D
    Clin Chim Acta; 2021 Jan; 512():40-48. PubMed ID: 33227269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
    Aguirre-Ruiz P; Ariceta B; Viguria MC; Zudaire MT; Blasco-Iturri Z; Arnedo P; Aguilera-Diaz A; Jauregui A; Mañú A; Prosper F; Mateos MC; Fernández-Mercado M; Larráyoz MJ; Redondo M; Calasanz MJ; Vázquez I; Bandrés E
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Cell Lineage-Specific Chimerism Testing by Next-Generation Sequencing for Engraftment Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu C; Dela Cruz T; Lai J; Kong D; Rajalingam R
    Methods Mol Biol; 2023; 2621():187-213. PubMed ID: 37041446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of dynamic monitoring of cell chimerism following allogeneic hematopoietic stem cell transplantation].
    Jiang Y; Wan LP; Wang C; Yan SK; Gao YR; Jiang JL; Yang J; Cai Y; Bai HT; Wei DL; Xie KC
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):667-71. PubMed ID: 19176059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [First report on assessment of the status of engraftment after allogeneic hematopoietic stem cell transplantation by using denaturing high-performance liquid chromatography].
    Wang Y; Pan KF; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):9-15. PubMed ID: 15748427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.
    Taira C; Matsuda K; Yamaguchi A; Uehara M; Sugano M; Okumura N; Honda T
    Clin Chim Acta; 2015 May; 445():101-6. PubMed ID: 25797898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of variable number tandem repeat and short tandem repeat genetic markers for qualitative and quantitative chimerism analysis post allogeneic stem cell transplantation.
    Mossallam GI; Smith AG; McFarland C
    J Egypt Natl Canc Inst; 2005 Jun; 17(2):103-13. PubMed ID: 16508681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of multiplex short tandem repeat (STR)-PCR for chimerism analysis in patients with hematological malignancies and comparison of chimerism in different sample sources].
    Taira C; Matsuda K; Takezawa Y; Ito T; Ishida F; Hidaka E; Kumagai T; Honda T
    Rinsho Byori; 2011 Jan; 59(1):24-30. PubMed ID: 21404576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.